Evaluation of the mucosal irritation potency of co-spray dried Amioca®/poly(acrylic acid) and Amioca®/Carbopol® 974P mixtures

Journal of Controlled Release

Volumn 88, Issue 3, 2003, Pages 393-399

  Adriaens, E ^a   Ameye, D ^a   Dhondt, M M M ^a   Foreman, P ^b   Remon, J P ^a  

^a GHENT UNIVERSITY   (Belgium)

^b NATIONAL STARCH AND CHEMICAL COMPANY   (United States)

Author keywords

Alternative test; Amioca Carbopol 974P co spray dried mixture; Amioca poly(acrylic acid) co spray dried mixture; Mucosal irritation; Slugs

Indexed keywords

ENZYMES; MIXTURES; TISSUE;

MUCOSAL IRRITATION POTENCY;

BIOCOMPATIBILITY;

AMIOCA; CARBOMER; CARBOPOL 974P; DRUG CARRIER; LACTATE DEHYDROGENASE; POLYACRYLIC ACID; STARCH;

AEROSOL; ARION LUSITANICUS; ARTICLE; BIOCOMPATIBILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MIXTURE; DRUG POTENCY; DRUG SCREENING; ENZYME RELEASE; ENZYME SYNTHESIS; INVERTEBRATE; MEMBRANE DAMAGE; MUCOSA INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; SPRAY DRYING;

EID: 0037467213     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(03)00012-9     Document Type: Article

References (21)

1. Kotze A.F., de Leeuw B.J., Luessen H.L., de Boer A.G., Verhoef J.C., Junginger H.E. Chitosans for enhanced delivery of therapeutic peptides across intestinal epithelia: In vitro evaluation in caco-2 cell monolayers. Int. J. Pharm. 159:(2):1997;243-253.
2. Yahagi R., Machida Y., Onishi H. Mucoadhesive suppositories of ramosetron hydrochloride utilizing Carbopol®. Int. J. Pharm. 193:(2):2000;205-212.
3. Ladipo O.A., De Castro M.P., Filho L., et al. A new vaginal antimicrobial contraceptive formulation: phase I clinical pilot studies. Contraception. 62:(2):2000;91-97.
4. Callens C., Remon J.P. Evaluation of starch-maltodextrin-Carbopol® 974P mixtures for the nasal delivery of insulin in rabbits. J. Control. Release. 66:(2-3):2000;215-220.
5. Veuillez F., Kalia Y.N., Jacques Y., Deshusses J., Buri P. Factors and strategies for improving buccal absorption of peptides. Eur. J. Pharm. Biopharm. 51:(2):2001;93-109.
6. Srividya B., Cardoza R.M., Amin P.D. Sustained ophthalmic delivery of ofloxacin from a pH triggered in situ gelling system. J. Control. Release. 73:(2-3):2001;205-211.
7. Dondeti P., Zia H., Needham T.E. Bioadhesive and formulation parameters affecting nasal absorption. Int. J. Pharm. 127:(2):1996;115-133.
8. Ahuja A., Khar R.K., Ali J. Mucoadhesive drug delivery systems. Drug Dev. Ind. Pharm. 23:(5):1997;489-515.
9. Witschi C., Mrsny R.J. In vitro evaluation of microparticles and polymer gels for use as nasal platforms for protein delivery. Pharm. Res. 16:(3):1999;382-390.
10. Ugwoke M.I., Agu R.U., Jorissen M., et al. Nasal toxicological investigations of Carbopol® 971P formulation of apomorphine: Effects on ciliary beat frequency of human nasal primary cell culture and in vivo on rabbit nasal mucosa. Eur. J. Pharm. Sci. 9:(4):2000;387-396.
11. Tengamnuay P., Sahamethapat A., Sailasuta A., Mitra A.K. Chitosans as nasal absorption enhancers of peptides: comparison between free amine chitosans and soluble salts. Int. J. Pharm. 197:(1-2):2000;53-67.
12. Balls M., Goldberg A.M., Fentem J.H., et al. The three Rs: the way forward - the report and recommendations of ECVAM workshop 11. Alternatives Lab. Animals. 23:(6):1995;838-866.
13. Adriaens E., Remon J.P. The evaluation of an alternative mucosal irritation test. Toxicol. Appl. Pharmacol. 182:(2):2002;169-175.
14. Callens C., Adriaens E., Dierckens K., Remon J.P. Toxicological evaluation of a bioadhesive nasal powder containing a starch and Carbopol® 974P on rabbit nasal mucosa and slug mucosa. J. Control. Rel. 76:(1-2):2001;81-89.
15. Adriaens E., Remon J.P. Gastropods as an evaluation tool for screening the irritating potency of absorption enhancers and drugs. Pharm. Res. 16:(8):1999;1240-1244.
16. Bottenberg P., Cleymaet R., Demuynck C., et al. Development and testing of bioadhesive, fluoride-containing slow-release tablets for oral use. J. Pharm. Pharmacol. 43:(7):1991;457-464.
17. Bouckaert S., Lefebvre R.A., Colardyn F., Remon J.P. Influence of the application site on bioadhesion and slow-release characteristics of a bioadhesive buccal slow-release tablet of miconazole. Eur. J. Clin. Pharmacol. 44:(4):1993;331-335.
18. Bouckaert S., Vakaet L., Remon J.P. Influence of the buccal application site of a bioadhesive slow-release tablet on salivary miconazole concentrations in irradiated patients. Int. J. Pharm. 130:(2):1996;257-260.
19. Ceulemans J., Vermeire A., Adriaens E., Remon J.P., Ludwig A. Evaluation of a mucoadhesive tablet for ocular use. J. Control. Release. 77:(3):2001;333-344.
20. Khanna R., Agarwal S.P., Ahuja A. Mucoadhesive buccal tablets of clotrimazole for oral candidiasis. Drug Dev. Ind. Pharm. 23:(8):1997;831-837.
21. Dash A.K., Gong Z., Miller D.W., Huai-Yan H., Laforet J.P. Development of a rectal nicotine delivery system for the treatment of ulcerative colitis. Int. J. Pharm. 190:(1):1999;21-34.